Contrast-Enhanced CISS/FIESTA Imaging for Increased Conspicuity of Pituitary Microadenomas in Cushing Disease

References

1. 1.↵
   1. Lonser RR,
   2. Wind JJ,
   3. Nieman LK, et al

   . Outcome of surgical treatment of 200 children with Cushing’s disease. J Clin Endocrinol Metab 2013;98:892–901 doi:10.1210/jc.2012-3604 pmid:23372173

   CrossRefPubMed
2. 2.↵
   1. Wagner-Bartak NA,
   2. Baiomy A,
   3. Habra MA, et al

   . Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol 2017;209:19–32 doi:10.2214/AJR.16.17290 pmid:28639924

   CrossRefPubMed
3. 3.↵
   1. Shih RY,
   2. Schroeder JW,
   3. Koeller KK

   . Primary tumors of the pituitary gland: radiologic-pathologic correlation. Radiographics 2021;41:2029–46 doi:10.1148/rg.2021200203 pmid:34597177

   CrossRefPubMed
4. 4.↵
   1. Castle-Kirszbaum M,
   2. Amukotuwa S,
   3. Fuller P, et al

   . MRI for Cushing disease: a systematic review. AJNR Am J Neuroradiol 2023;44:311–16 doi:10.3174/ajnr.A7789 pmid:36759141

   Abstract/FREE Full Text
5. 5.↵
   1. Grober Y,
   2. Grober H,
   3. Wintermark M, et al

   . Comparison of MRI techniques for detecting microadenomas in Cushing’s disease. J Neurosurg 2018;128:1051–57 doi:10.3171/2017.3.JNS163122 pmid:28452619

   CrossRefPubMed
6. 6.↵
   1. Kasaliwal R,
   2. Sankhe SS,
   3. Lila AR, et al

   . Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas. Clin Endocrinol (Oxf) 2013;78:825–30 doi:10.1111/cen.12069 pmid:23061773

   CrossRefPubMed
7. 7.↵
   1. Bernstein Ma KK,
   2. Zhou XJ

   . Handbook of MRI Pulse Sequences. Elsevier; 2004
8. 8.↵
   1. Li Z,
   2. Chen YA,
   3. Chow D, et al

   . Practical applications of CISS MRI in spine imaging. Eur J Radiol Open 2019;6:231–42 doi:10.1016/j.ejro.2019.06.001 pmid:31304197

   CrossRefPubMed
9. 9.↵
   1. Noble DJ,
   2. Scoffings D,
   3. Ajithkumar T, et al

   . Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves. Br J Radiol 2016;89:20160392 doi:10.1259/bjr.20160392 pmid:27636022

   CrossRefPubMed
10. 10.↵
    1. Blitz AM,
    2. Macedo LL,
    3. Chonka ZD, et al

    . High-resolution CISS MR imaging with and without contrast for evaluation of the upper cranial nerves: segmental anatomy and selected pathologic conditions of the cisternal through extraforaminal segments. Neuroimaging Clin N Am 2014;24:17–34 doi:10.1016/j.nic.2013.03.021 pmid:24210310

    CrossRefPubMed
11. 11.↵
    1. Chavhan GB,
    2. Babyn PS,
    3. Jankharia BG, et al

    . Steady-state MR imaging sequences: physics, classification, and clinical applications. Radiographics 2008;28:1147–60 doi:10.1148/rg.284075031 pmid:18635634

    CrossRefPubMed
12. 12.↵
    1. Casselman JW,
    2. Kuhweide R,
    3. Deimling M, et al

    . Constructive interference in steady state-3DFT MR imaging of the inner ear and cerebellopontine angle. AJNR Am J Neuroradiol 1993;14:47–57 pmid:8427111

    Abstract/FREE Full Text
13. 13.↵
    1. Blitz AM,
    2. Northcutt B,
    3. Shin J, et al

    . Contrast-enhanced CISS imaging for evaluation of neurovascular compression in trigeminal neuralgia: improved correlation with symptoms and prediction of surgical outcomes. AJNR Am J Neuroradiol 2018;39:1724–32 doi:10.3174/ajnr.A5743 pmid:30139749

    Abstract/FREE Full Text
14. 14.↵
    1. Lang M,
    2. Habboub G,
    3. Moon D, et al

    . Comparison of constructive interference in steady-state and T1-weighted MRI sequence at detecting pituitary adenomas in Cushing’s disease patients. J Neurol Surg B Skull Base 2018;79:593–98 doi:10.1055/s-0038-1642032 pmid:30456030

    CrossRefPubMed
15. 15.↵
    1. Braileanu M,
    2. Hu R,
    3. Hoch MJ, et al

    . Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection. Clin Imaging 2019;55:29–34 doi:10.1016/j.clinimag.2019.01.020 pmid:30731423

    CrossRefPubMed
16. 16.↵
    1. Kim LJ,
    2. Lekovic GP,
    3. White WL, et al

    . Preliminary experience with 3-Tesla MRI and Cushing’s disease. Skull Base 2007;17:273–77 doi:10.1055/s-2007-985196 pmid:18174929

    CrossRefPubMed
17. 17.↵
    1. Nakazawa H,
    2. Shibamoto Y,
    3. Tsugawa T, et al

    . Efficacy of magnetic resonance imaging at 3 T compared with 1.5 T in small pituitary tumors for stereotactic radiosurgery planning. Jpn J Radiol 2014;32:22–29 doi:10.1007/s11604-013-0262-0 pmid:24248770

    CrossRefPubMed
18. 18.↵
    1. Varrassi M,
    2. Cobianchi Bellisari F,
    3. Bruno F, et al

    . High-resolution magnetic resonance imaging at 3T of pituitary gland: advantages and pitfalls. Gland Surg 2019;8:S208–15 doi:10.21037/gs.2019.06.08 pmid:31559187

    CrossRefPubMed
19. 19.↵
    1. Tong T,
    2. Yue W,
    3. Zhong Y, et al

    . Comparison of contrast-enhanced SPACE and CISS in evaluating cavernous sinus invasion by pituitary macroadenomas on 3-T magnetic resonance. J Comput Assist Tomogr 2015;39:222–27 doi:10.1097/RCT.0000000000000191 pmid:25526399

    CrossRefPubMed
20. 20.↵
    1. Mark IT,
    2. Welker K,
    3. Erickson D, et al

    . 7T MRI for Cushing disease: a single-institution experience and literature review. AJNR Am J Neuroradiol 2024;45:971–76 doi:10.3174/ajnr.A8209 pmid:38365424

    Abstract/FREE Full Text
21. 21.↵
    1. Potts MB,
    2. Shah JK,
    3. Molinaro AM, et al

    . Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing’s disease. J Neurooncol 2014;116:593–600 doi:10.1007/s11060-013-1342-9 pmid:24398617

    CrossRefPubMed
22. 22.↵
    1. Chatain GP,
    2. Patronas N,
    3. Smirniotopoulos JG, et al

    . Potential utility of FLAIR in MRI-negative Cushing’s disease. J Neurosurg 2018;129:620–28 doi:10.3171/2017.4.JNS17234 pmid:29027863

    CrossRefPubMed
23. 23.↵
    1. Osawa I,
    2. Nagawa K,
    3. Hara Y, et al

    . Utility of contrast-enhanced 3D STIR FLAIR imaging for evaluating pituitary adenomas at 3 Tesla. Eur J Radiol Open 2023;11:100500 doi:10.1016/j.ejro.2023.100500 pmid:37408663

    CrossRefPubMed
24. 24.
    1. Mark IT,
    2. Yu L

    . Photon-counting detector CT iodine maps for pituitary adenoma in Cushing disease. AJR Am J Roentgenol 2024;223:e2431418 doi:10.2214/AJR.24.31418 pmid:38838233

    CrossRefPubMed
25. 25.
    1. Mark IT,
    2. Van Gompel J,
    3. Bancos I, et al

    . Back to the future: dynamic contrast-enhanced photon-counting detector CT for the detection of pituitary adenoma in Cushing disease. AJNR Am J Neuroradiol 2024;45:743–46 doi:10.3174/ajnr.A8171 pmid:38290737

    Abstract/FREE Full Text